glp 1 agonist perioperative How should we approach patients on GLP-1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like New therapeutic agents for type

By 2040, 50% of the global population will have fatty liver disease, and most people have never even heard of it

Different peptides may be used for different purposes, which is why treatment plans often vary from person to person

NAC provides a cost-effective foundation for natural glutathione production, whilst direct glutathione supplementation delivers faster results for skin concerns

L-Theanine L-Theanine, primarily found in tea leaves (e.g

The consistent doseresponse effect observed between the D and D + S groups further reinforces the central role of biochemical supplementation in overcoming the metabolic inertia inherent to T21

L-carnitines bioavailability varies between 50% and 85% depending on the amount of dietary carnitine consumed: the higher the intake, the lower the availability (8-9)